CD4 and breast cancer: In 2020, Sui et al. constructed an immune prognostic model based on 6 immune cells which were significantly related to the OS of BC patients, including resting CD4+ T cells, Treg cells, gamma‐delta T cells, activated NK cells, monocytes and M0 macrophages.37